Company Filing History:
Years Active: 2000
Title: The Innovations of Dyung Aina Lu
Introduction
Dyung Aina Lu is an accomplished inventor based in San Jose, CA. He has made significant contributions to the field of biotechnology, particularly in the development of human RNA binding proteins and protein kinase homologs. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
One of Dyung Aina Lu's latest patents focuses on human RNA binding proteins. This invention provides human RNA binding proteins (RNABP) and polynucleotides that identify and encode RNABP. It also includes expression vectors, host cells, antibodies, agonists, and antagonists. Furthermore, the invention outlines methods for diagnosing, treating, or preventing disorders associated with the expression of RNABP. Another significant patent involves human protein kinase homologs (PKH). This invention offers human protein kinase homologs and polynucleotides that identify and encode PKH. Similar to his previous patent, it provides expression vectors, host cells, antibodies, agonists, and antagonists, along with methods for diagnosing, treating, or preventing disorders related to PKH expression.
Career Highlights
Dyung Aina Lu is currently employed at Incyte Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work at Incyte has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of Dyung Aina Lu's notable coworkers include Olga Bandman and Karl J Guegler. Their collaborative efforts contribute to the innovative environment at Incyte Pharmaceuticals.
Conclusion
Dyung Aina Lu's contributions to biotechnology through his patents on RNA binding proteins and protein kinase homologs demonstrate his commitment to advancing medical science. His work has the potential to lead to significant advancements in diagnosing and treating various disorders.